International Journal of Applied Behavioral Sciences

Schulz, K. H., Gold, S. M., Witte, J.,Bartsch, K., Lang, U. E., Hellweg, R., ... &Heesen, C. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. Journal of the Neurolog Sciences. 2004;225(1), 11-18.

Greer JM, McCombe PA. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuro immunol. 2011; 234(1–2):7–18.

Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993; 116 (1):117–348.

Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989; 112 (1):133–46.

Induruwa, I., Constantinescu, C. S., & Gran, B. Fatigue in multiple sclerosis-a brief review. Journal of the Neurological Sciences. 2012; 323(1), 9-15.

Ismaili, Maryam; Hosseini, Fatima. Multiple Sclerosis and Stressful Habits. Nursing Research. 2008; 3 (10-11): 30-23.

Losy, J., & Michałowska‐Wender, G. In vivo effect of interferon‐β 1a on interleukin‐12 and TGF‐β1 cytokines in

patients with relapsing–remitting multiple sclerosis. Acta Neurologica Scandinavica. 2002; 106(1), 44-46.

Cohen, S., & Herbert, T. B. Health psychology: Psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annual Rev of Psychology. 1996; 47(1), 113-142.

Schulenborg, T., Schmidt, O., Van Hall, A., Meyer, H. E., Hamacher, M., & Marcus, K.Proteomics in neurodegeneration–disease driven approaches. Journal of Neural Transmission. 2006; 113(8), 1055-1073.

Alexander, J. S., Harris, M. K., Wells, S. R., Mills, G., Chalamidas, K., Ganta, V. C., ... & Minagar, A. Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-β1b. MS Journal. 2010; 16(7), 801-809.

Van Boxel-Dezaire, A. H. H., Hoff, S. C. J., Van Oosten, B. W., Verweij, C. L., Dräger, A. M., Ader, H. J., ... & Nagelkerken, L. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Annals of Neurology. 1999; 45(6), 695-703.

Van Boxel-Dezaire, A. H. H., van TrigtHoff, S. C. J., Killestein, J., Schrijver, H. M., Van Houwelingen, J. C., Polman, C. H., & Nagelkerken, L. Contrasting responses to interferon β‐1 b treatment in relapsing‐ remitting multiple sclerosis: Does baseline interleukin‐12 p 35 messenger RNA predict the efficacy of treatment?. Annals of Neurology. 2000; 48(3), 313-322.

Özenci, V., Pashenkov, M., Kouwenhoven, M., Rinaldi, L., Söderström, M., & Link, H. IL-12/IL-12R system in multiple sclerosis. Journal of Neuro immunology. 2001; 114(1), 242-252.

Heesen, C., Sieverding, F., Schoser, B. G. H., Hadji, B., & Kunze, K. Interleukin‐12 is detectable in sera of patients with multiple sclerosis—association with chronic progressive disease course?. European Journal of Neurology. 1999; 6(5), 591-596.

Jones, M. E., Lebonville, C. L., Paniccia, J. E., Balentine, M. E., Reissner, K. J., & Lysle, D. T.. Hippocampal interleukin-1 mediates stress-enhanced fear learning: A potential role for astrocyte-derived interleukin-1β. Brain, Behavior, and Immunity. 2018; 67, 355-363.

Marsland, A. L., Walsh, C., Lockwood, K., & John-Henderson, N. A. The effects of acute psychological stress on circulating and stimulated inflammatory markers: a systematic review and meta-analysis. Brain, Behavior, and Immunity. 2017; 64, 208-219.

Felton, J. W., Banducci, A. N., Shadur, J. M., Stadnik, R., MacPherson, L., & Lejuez, C. W.. The developmental trajectory of perceived stress mediates the relations between distress tolerance and internalizing symptoms among youth. Development and Psychopathology. 2017; 1-11.

Bardeen, J. R., Fergus, T. A., & Orcutt, H.K. Examining the specific dimensions of distress tolerance that prospectively predict perceived stress. CBT Journal. 2017; 46(3), 211-223.

Carlson, L. E., Ursuliak, Z., Goodey, E., Angen, M., & Speca, M. The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. Supportive Care in Cancer, 2001; 9(2), 112-123.

Antoni, M. H., Ironson, G., & Schneiderman, N. Cognitive-behavioral stress management. Oxford University

Press. (2007).

Pakenham, K. I., Scott, T., & Uccelli, M. M. Evaluation of Acceptance and Commitment Therapy Training for

Psychologists Working with People with Multiple Sclerosis. International Journal of MS Care. 2018; 20(1), 44-48.

Nikoogoftar Mansoureh, Khanalilu Roya. Comparison of the effectiveness of cognitive behavioral therapy and

acceptance-based therapy on reducing depression symptoms in female patients with Multiple Sclerosis (MS) Journal of Behavioral Sciences Research. 2017; 51 (5): 15-66.

Sheppard, S. C., Forsyth, J. P., Hickling, E. J., & Bianchi, J. A novel application of acceptance and commitment therapy for psychosocial problems associated with multiple sclerosis: Results from a half-day workshop intervention. International Journal of MS Care. 2010; 12(4), 200-206.

Hayes, S. C., Strosahl, K. D., & Wilson, K. G. Acceptance and commitment therapy: An experiential approach to behavior change. New York, NY: Guilford Press. (1999).

Vallis, M., Ruggiero, L., Greene, G., Jones, H., Zinman, B., Rossi, S., Edwards, L., Rossi, J.S., & Prochaska, J.O. Stages of Change for Healthy Eating in Diabetes Relation to demographic, eating-related, health care utilization, and psychosocial factors. Diabetes Care. 2003; 26(5), 1468- 1474.

Forman, E.M., & Herbert, D. New directions in cognitive behavior therapy: acceptance based therapies, chapter to appear. In: O'Donohue WT, Fisher, JE, editors. Cognitive behavior therapy: applying empirically supported techniques in your practice. 2nd ed. Hoboken, NJ: John Wiley & Sons. 2009; 263-8. 27. Moreira, F.P., de Azevedo Cardoso, T., Mondin, T.C., de Mattos Souza, L.D., Silva, R., Jansen, K., Oses, J.P., & Wiener,

C.D. The effect of proinflammatory cytokines in Cognitive Behavioral Therapy. Journal of Neuro immunology. 2015; 285, 143-146.

Erwin, M.R., Olmstead, R., Breen, E.C., Witarama, T., Carrillo, C., Sadeghi, N., Arevalo, J.M., Ma, J., Nicassio, P., Bootzin, R., & Cole, S. Cognitive behavioral therapy and tai chi reverse cellular and genomic markers of inflammation in late-life insomnia: a randomized controlled trial. Biological Psychiatry. 2015; 78(10), 721-729.

Lattie, E. G. The Effects of TelephoneDelivered Cognitive Behavioral Stress Management on Inflammation and

Symptoms in Myalgic Enchephalomyelitis/Chronic Fatigue Syndrome: A Computational Immunology Approach (Doctoral dissertation). University of Miami Scholarly Repository. (2015).

Zavari Zare, Parvaneh; Zavari Zare, Azar; Ebrahimi Pakizeh, Behrouz. The Effectiveness of Acceptance and

Commitment Therapy on Negative Emotions in Patients with MS. Fourth National Conference on Sustainable

Development in Education and Psychology, Social and Cultural Studies. 2016; 5-8.

De Oliveira, J.F., Wiener, C.D., Jansen, K., Portela, L.V., Lara, D.R., de Mattos Souza, L.D., da Silva, R.A., Moreira, F.P., & Oses, J.P. Serum levels of interleukins IL-6 and IL-10 in individuals with posttraumatic stress disorder in a population-based sample. Psychiatry Research. 2018; 260, 111-115.

Song, C., Li, X., Leonard, B. E., & Horrobin, D. F. Effects of dietary n-3 or n-6 fatty acids on interleukin-1β-induced anxiety, stress, and inflammatory responses in rats. Journal of Lipid Research. 2003; 44(10), 1984-1991.

Kim, Y. K., Suh, I. B., Kim, H., Han, C. S., Lim, C. S., Choi, S. H., & Licinio, J. The plasma levels of interleukin-12 in

schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Molecular Psychiatry. 2002; 7(10), 1107.

Thompson, A.J., Banwell, B.R., Barkhof, F., Carroll, W.M., Coetzee, T., Comi, G. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, 2018; 17(2), 162-173

Hall, D. L. Effects of telephone-delivered cognitive behavioral stress management intervention on fatigue interference and neuroimmune function in chronic fatigue syndrome (Doctoral dissertation, University

of Miami). (2016).

Berk, L.S., Bellinger, D.L., Koenig, H.G., Daher, N., Pearce, M.J., Robins, C.J., Nelson, B., Shaw, S.F., Cohen, H.J., &

King, M.B. Effects of religious vs. conventional cognitive-behavioral therapy on inflammatory markers and stress

hormones in major depression and chronic medical illness: A randomized clinical trial. Open Journal of Psychiatry. 2015; 5(03),238.

Chen, H.Y., Cheng, I.C., Pan, Y.J., Chiu, Y.L., Hsu, S.P., Pai, M.F., Yang, J.Y., Peng, Y.S., Tsai, T.J., & Wu, K.D.

Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in

hemodialysis patients. Kidney International. 2011; 80(4), 415-422.

Gardner, C. M. exploring the effects of Acceptance and Commitment Therapy (ACT) on biomarkers of stress in breast cancer survivors (Doctoral dissertation, University of Southern Queensland).(2018).

Baradaran, Majid; Zare, Hossein; Alipour, Ahmad; Farzad, Valliallah. The Effectiveness of Commitment-Based and Acceptance Therapy on Cognitive Fusion and Physical Health Indicators of Patients with Essential Hypertension. Journal of Cognitive Psychology. 2016; 4(2-5): .5-5

Steptoe, A., Hamer, M., & Chida, Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain, Behavior and Immunity. 2007; 21(7), 901-912.

Brydon, L., Edwards, S., Mohamed-Ali, V., & Steptoe, A. Socioeconomic status and stress-induced increases in interleukin-6. Brain, Behavior and Immunity. 2004; 18(3), 281-290.

Kunz-Ebrecht, S. R., Mohamed-Ali, V., Feldman, P. J., Kirschbaum, C., & Steptoe, A. Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain, Behavior, and Immunity. 2003; 17(5), 373-383.

Reynard, A. K., Sullivan, A. B., & RaeGrant, A. A systematic review of stressmanagement interventions for multiple sclerosis patients. International Journal of MS Care. 2014; 16(3), 140-144. 44. Antoni, M.H., Lechner, S., Diaz, A., Vargas, S., Holley, H., Phillips, K., McGregor, B., Carver, C.S., & Blomberg, B. Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment

for breast cancer. Brain, Behavior, and Immunity. 2009; 23(5), 580-591.

Shibani, Farshad. Comparison of the effectiveness of mindfulness-based stress reduction intervention and cognitivebehavioral stress management intervention on biological markers and psychological symptoms in patients with major hypertension. Doctoral Thesis, Department of Clinical Psychology, Iran University of

Medical Sciences. (2018).

Levenstein, S., Prantera, C., Varvo, V., Scribano, M.L., Andreoli, A., Luzi, C., Arca, M., Berto, E., Milite, G., &

Marcheggiano, A. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. The American Journal of Gastroenterology. 2000; 95(5), 1213-1220.

Mawdsley, J. E., & Rampton, D. S. Psychological stress in IBD: new insights into pathogenic and therapeutic

implications. Gut, 2005; 54(10), 1481- 1491.

Shokouhiyekta, M., & Parand, A. Strategies for stress management. Sepidbarg Publication. (2012).

Chandola, T., Heraclides, A., & Kumari, M. Psychophysiological biomarkers of workplace stressors. Neuroscience & Biobehavioral Reviews. 2010; 35(1), 51-57.